trial

A Study of a Remediation Program of Social Cognition in Schizophrenia

NCTId NCT01077791
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 2 · Terminated
Enrollment 26 (actual)
Sponsored by Assistance Publique - Hôpitaux de Paris
Primary completion 2010-09
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 2
Status
Terminated
Enrollment
26 (actual)
Study type
Interventional
Allocation
Randomized
Model
Single Group
Masking
Single
Start
2008-07
Primary completion
2010-09
Eligibility
ALL · 18 Years · 57 Years

Interventions & indications

Drugs
original cognitive therapy

Sponsors

Assistance Publique - Hôpitaux de ParisLead Sponsor

Investigators

1
Catherine Bourdet, MDPrincipal Investigator

Sites

1 total
Le Chesnay, France

Linked catalysts

1
A Study of a Remediation Program of Social Cognition in Schizophrenia — primary completion2010-09

Facts & assertions

4 sourced
Enrollment
26
Phase
PHASE2
Primary Completion Date
2010-09
Status
TERMINATED
relationships
The graph out of here
drug
original cognitive therapy
drug
lead_sponsor
Assistance Publique - Hôpitaux de Paris
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Catherine Bourdet, MD
person